131 related articles for article (PubMed ID: 9952020)
1. Rapid activation of the alternative pathway of complement by extracorporeal membrane oxygenation.
Vallhonrat H; Swinford RD; Ingelfinger JR; Williams WW; Ryan DP; Tolkoff-Rubin N; Cosimi AB; Pascual M
ASAIO J; 1999; 45(1):113-4. PubMed ID: 9952020
[TBL] [Abstract][Full Text] [Related]
2. In vivo generation of C4d, Bb, iC3b, and SC5b-9 after OKT3 administration in kidney and lung transplant recipients.
Vallhonrat H; Williams WW; Cosimi AB; Tolkoff-Rubin N; Ginns LC; Wain JC; Preffer F; Olszak I; Wee S; Delmonico FL; Pascual M
Transplantation; 1999 Jan; 67(2):253-8. PubMed ID: 10075589
[TBL] [Abstract][Full Text] [Related]
3. Synovial fluid levels of complement SC5b-9 and fragment Bb are elevated in patients with rheumatoid arthritis.
Brodeur JP; Ruddy S; Schwartz LB; Moxley G
Arthritis Rheum; 1991 Dec; 34(12):1531-7. PubMed ID: 1747138
[TBL] [Abstract][Full Text] [Related]
4. Complement activation in severe Plasmodium falciparum malaria.
Wenisch C; Spitzauer S; Florris-Linau K; Rumpold H; Vannaphan S; Parschalk B; Graninger W; Looareesuwan S
Clin Immunol Immunopathol; 1997 Nov; 85(2):166-71. PubMed ID: 9344699
[TBL] [Abstract][Full Text] [Related]
5. Alterations in C3, C4, factor B, and related metabolites in septic shock.
Lin RY; Astiz ME; Saxon JC; Saha DC; Rackow EC
Clin Immunol Immunopathol; 1993 Nov; 69(2):136-42. PubMed ID: 8403550
[TBL] [Abstract][Full Text] [Related]
6. Activation of the alternative pathway of complement in psoriatic lesional skin.
Takematsu H; Tagami H
Dermatologica; 1990; 181(4):289-92. PubMed ID: 2073958
[TBL] [Abstract][Full Text] [Related]
7. Complement fragment C4d and Bb levels in inflammatory skin diseases (e.g. SLE, atopic dermatitis, erythroderma and pustulosis palmaris et plantaris) for assessment of complement activation.
Takematsu H; Tagami H
Tohoku J Exp Med; 1991 Apr; 163(4):263-8. PubMed ID: 1831937
[TBL] [Abstract][Full Text] [Related]
8. Elevated levels of iC3b and C4d, but not Bb, complement fragments from plasma of persons infected with human T cell leukemia virus (HTLV) with HTLV-I-associated myelopathy/tropical spastic paraparesis.
Saarloos MN; Koenig RE; Spear GT
J Infect Dis; 1995 Oct; 172(4):1095-7. PubMed ID: 7561187
[TBL] [Abstract][Full Text] [Related]
9. Complement activation during painful crisis in sickle cell anemia.
Mold C; Tamerius JD; Phillips G
Clin Immunol Immunopathol; 1995 Sep; 76(3 Pt 1):314-20. PubMed ID: 7554454
[TBL] [Abstract][Full Text] [Related]
10. Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum.
Mayes JT; Schreiber RD; Cooper NR
J Clin Invest; 1984 Jan; 73(1):160-70. PubMed ID: 6418767
[TBL] [Abstract][Full Text] [Related]
11. Generation of the membrane attack complex during haemodialysis: impact of classical and alternative pathway components.
Hauser AC; Derfler K; Stockenhuber F; Janata O; Balcke P
Clin Sci (Lond); 1990 Nov; 79(5):471-6. PubMed ID: 2174314
[TBL] [Abstract][Full Text] [Related]
12. Role of atheroma liposomes and malondialdehyde-modified low-density lipoproteins in complement activation.
Sorace JM; Rollins S; Aniagolu JU; Mergner WJ; Cole K; Swartz GM; Green SJ
Pathobiology; 1996; 64(2):73-8. PubMed ID: 8888272
[TBL] [Abstract][Full Text] [Related]
13. Studies on protein adsorption and activation of complement on hydrated aluminium surfaces in vitro.
Tengvall P; Askendal A; Lundström I
Biomaterials; 1998 May; 19(10):935-40. PubMed ID: 9690835
[TBL] [Abstract][Full Text] [Related]
14. Pleural SC5b-9 in differential diagnosis of tuberculous, malignant, and other effusions.
Hara N; Abe M; Inuzuka S; Kawarada Y; Shigematsu N
Chest; 1992 Oct; 102(4):1060-4. PubMed ID: 1395743
[TBL] [Abstract][Full Text] [Related]
15. Preferential activation of the alternative pathway of complement in psoriatic lesional skin.
Takematsu H; Tagami H
Dermatology; 1992; 184(2):159-60. PubMed ID: 1498383
[No Abstract] [Full Text] [Related]
16. The terminal complement complex (sC5b-9) is not specifically associated with the development of the adult respiratory distress syndrome.
Parsons PE; Giclas PC
Am Rev Respir Dis; 1990 Jan; 141(1):98-103. PubMed ID: 2297192
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity and specificity of plasma and urine complement split products as indicators of lupus disease activity.
Manzi S; Rairie JE; Carpenter AB; Kelly RH; Jagarlapudi SP; Sereika SM; Medsger TA; Ramsey-Goldman R
Arthritis Rheum; 1996 Jul; 39(7):1178-88. PubMed ID: 8670328
[TBL] [Abstract][Full Text] [Related]
18. Complement activation products in plasma after heart transplantation in humans.
Vallhonrat H; Williams WW; Dec GW; Keck S; Schoenfeld D; Cosimi AB; Pascual M
Transplantation; 2001 May; 71(9):1308-11. PubMed ID: 11397968
[TBL] [Abstract][Full Text] [Related]
19. Complement activation by in vivo neonatal and in vitro extracorporeal membrane oxygenation.
Graulich J; Sonntag J; Marcinkowski M; Bauer K; Kössel H; Bührer C; Obladen M; Versmold HT
Mediators Inflamm; 2002 Apr; 11(2):69-73. PubMed ID: 12061426
[TBL] [Abstract][Full Text] [Related]
20. [In-vivo activation of the 4th component of the complement system (C4) in premature and term infants with generalized bacterial infections].
Nürnberger W; Stannigel H; Müntel V; Michelmann I; Wahn V; Göbel U
Klin Padiatr; 1990; 202(3):141-6. PubMed ID: 2355716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]